日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Timing-specific efficacy of antiviral baloxavir and anti-inflammatory oclacitinib monotherapies, and the benefits of their combination in treating influenza in mice

抗病毒药物巴洛沙韦和抗炎药物奥克拉替尼单药治疗的时间特异性疗效,以及二者联合用药治疗小鼠流感的益处

Yu, Yang; Jiang, Lefang; Ke, Jiaxin; Lian, Xiaoqin; Gao, Yarou; Zhu, Xingjian; Zhang, Mingxin; Wu, Huixia; Chen, Xulin

Targeting the 5-HT7 receptor to block influenza virus entry: mechanistic insights and therapeutic potential of SB269970 HCl

靶向5-HT7受体阻断流感病毒入侵:SB269970 HCl的作用机制及治疗潜力

Gao, Yarou; Zhu, Xingjian; Ke, Jiaxin; Su, Yue; Lian, Xiaoqin; Jiang, Lefang; Zhang, Mingxin; Yu, Yang; Peng, Qun; Chen, Xulin

Screening of neurotransmitter receptor modulators reveals novel inhibitors of influenza virus replication.

神经递质受体调节剂的筛选揭示了流感病毒复制的新型抑制剂

Gao Yarou, Liu Ge, Ma Yirui, Su Yue, Lian Xiaoqin, Jiang Lefang, Ke Jiaxin, Zhu Xingjian, Zhang Mingxin, Yu Yang, Peng Qun, Zhao Wei, Chen Xulin

LDC000067, a CDK9 inhibitor, unveils promising results in suppressing influenza virus infections in vitro and in vivo

CDK9抑制剂LDC000067在体外和体内抑制流感病毒感染方面均展现出良好的效果。

Zhang, Mingxin; Lian, Xiaoqin; Gao, Yarou; Jiang, Lefang; Li, Zhuogang; Zhang, Haonan; Su, Yue; Peng, Qun; Chen, Xulin

Screening and identification of host signaling pathways for alleviating influenza-induced production of pro-inflammatory cytokines, IP-10, IL-8, and MCP-1, using a U937 cell-based influenza model.

利用 U937 细胞流感模型筛选和鉴定宿主信号通路,以减轻流感诱导的促炎细胞因子 IP-10、IL-8 和 MCP-1 的产生

Chen Si, Yu Yang, Su Yue, Lian Xiaoqin, Jiang Lefang, Li Zhuogang, Zhang Mingxin, Gao Yarou, Zhang Haonan, Zhu Xingjian, Ke Jiaxin, Chen Xulin